2013
DOI: 10.4161/cc.24309
|View full text |Cite
|
Sign up to set email alerts
|

Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
42
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 35 publications
(45 citation statements)
references
References 71 publications
(93 reference statements)
0
42
0
Order By: Relevance
“…This correlated with an accumulation of p53 protein and induction of apoptosis in the embryonic stem cells in hypoxia (Supplemental Figure 4E). These data together demondescribed as a p53 target gene with 2 p53 REs in intron 9 (36). We carried out ChIP analysis using both these REs and found that one of them was moderately enriched for p53 binding in hypoxia (Supplemental Figure 4A).…”
Section: Resultsmentioning
confidence: 99%
“…This correlated with an accumulation of p53 protein and induction of apoptosis in the embryonic stem cells in hypoxia (Supplemental Figure 4E). These data together demondescribed as a p53 target gene with 2 p53 REs in intron 9 (36). We carried out ChIP analysis using both these REs and found that one of them was moderately enriched for p53 binding in hypoxia (Supplemental Figure 4A).…”
Section: Resultsmentioning
confidence: 99%
“…1 Although the role of p53 is generally considered to be at the level of transactivation via binding to target sequences, there are several other ways by which it can determine its cellular responses including, for example, interaction with other transcription factors. 2 Post-transcriptional and translational controls provide fine tuning of transcriptional outcomes in eukaryotic somatic cells. 3 More than 90% of all coding transcripts appear to be subject to this regulation, especially at translation initiation, 4 considered as the rate-limiting step of the whole process.…”
mentioning
confidence: 99%
“…59 Rapamycin (Sigma-Aldrich)-Torin1 (Tocris Bioscience, Bristol, UK). Proteins were extracted using RIPA buffer as previously described, 2 supplemented with protease inhibitors and phosphatase inhibitor cocktail2 (Sigma-Aldrich) and quantified using the BCA assay (Thermo Scientific, Pierce, Milan, Italy). The relative molecular mass of the immunoreactive bands was determined using PageRuler Plus Prestained Protein Ladder (Fermentas).…”
mentioning
confidence: 99%
“…Acting as an inhibitor of the PI3K pathway, INPP5D is considered as a tumor suppressor in acute myeloid leukemia, Hodgkin's lymphoma, and acute lymphoblastic leukemia (Luo et al 2004;Metzner et al 2009;Tiacci et al 2012). Besides, INPP5D has been found as the target of the cellular tumor antigen p53 in human breast cancer adenocarcinoma MCF7 cells and testicular germ cell tumor-derived human embryonal carcinoma cells (Kerley-Hamilton et al 2005;Lion et al 2013). Although the role INPP5D plays in prostate tumor cells has not been established, it is possible that INPP5D contributes to prostate cancer progression through the PI3K or p53 pathway.…”
Section: Discussionmentioning
confidence: 99%